Targeted protein replacement for the treatment of lysosomal storage disorders
The present invention relates to compositions and methods for delivering lysosomal proteins. The compositions and methods described herein permit the targeted delivery of exogenous lysosomal proteins to cell surface proteins that allow their internalization via non-clathrin pathways. The present invention further relates to the use of the compositions and methods for enzyme replacement therapy of lysosomal storage diseases. Nucleic acids, recombinant cells and kits useful for making and using the compositions of the invention are also provided.
1. A nucleic acid comprising a nucleotide sequence encoding a fusion protein comprising a mammalian acid sphingomyelinase or active fragment thereof covalently attached to a targeting moiety, wherein the targeting moiety binds to an extracellular portion of Intracellular Adhesion Molecule-1 (ICAM-1) or Platelet Endothelial Cell Adhesion Molecule (PECAM-1).
2. The nucleic acid of claim 1 in which the nucleotide sequence is operably linked to a promoter.
3. An isolated host cell which comprises in its genome the nucleic acid of claim 1 .
4. A method for producing a fusion protein comprising a mammalian acid sphingomyelinase or active fragment thereof which is covalently attached to a targeting moiety, wherein the targeting moiety binds to an extracellular portion of Intracellular Adhesion Molecule-1 (ICAM-1) or Platelet Endothelial Cell Adhesion Molecule (PECAM-1), said method comprising:
(a) culturing the isolated host cell of claim 3 under conditions in which the mammalian acid sphingomyelinase or active fragment covalently attached to the targeting moiety is expressed and
(b) recovering the expressed mammalian acid sphingomyelinase or active fragment covalently attached to the targeting moiety.
5. The method of claim 4 , in which the isolated host cell is a mammalian cell in culture.